Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights

GlobeNewswire
2025.11.10 22:03

Actively enrolling Cohort 3 ( FTD-GRN ) and Cohort 4 ( FTD-C9orf72 ) patients in ongoing upliFT-D study ...